Though the CDC claims 20 percent of U.S. children may have a mental disorder, critics have pointed out several other reasons for the allegedly higher numbers.
HHS Secretary Kathleen Sebelius told the World Health Assembly on May 20 that "universal health coverage" is a "right" that "national governments" must enact.
A class action lawsuit alleges that the IRS illegally stole the medical records of more than 10 million Americans in the course of investigating a single individual.
Thursday's House vote was strictly political. As implementation of ObamaCare takes place over the next couple of years, Americans will finally be able to "see what's in the bill," and Republicans want to be on the right side of that issue come 2014 and 2016.
Data provided to a House committee by insurance companies suggest that premiums are likely to go through the roof when ObamaCare is fully implemented in January.
Colorado's health insurance exchange, believed to be one of the country's most efficient, may ask for another $125 million from Washington in part to educate the public about ObamaCare.
A federal judge Friday turned down a request by government lawyers to suspend his decision that the "morning after" contraceptive pill be available for the over-the counter purchase by girls of any age.
House Speaker John Boehner and Senate Minority Leader Mitch McConnell told President Obama they would not cooperate in appointing members of ObamaCare's Independent Payment Advisory Board, which has the power to deny care to seniors.
A group of individuals and small businesses is suing the IRS for ruling that individuals in states that do not establish insurance exchanges are eligible for premium subsidies in direct contravention of the ObamaCare law.
On Tuesday, the United States Food and Drug Administration (FDA) announced that it would allow the Plan B One-Step contraceptive to be sold without prescription to females as young as 15. The announcement amends a December 2011 decision that prohibited the sale of emergency contraceptives to all females of reproductive age without restriction, which had been overturned by a U.S. District judge on April 5. According to the FDA, its latest announcement was not prompted by the judge’s ruling, but is based on a study released by the company that makes the Plan B drug.